IPO Inventiva

Listing of Inventiva on Euronext

Frédéric Cren, Chairman and CEO and Co-Founder of Inventiva, opens the trading day in Paris.

Inventiva specializes in the research and development of therapeutic products for the treatment of Parkinson's disease, cancer, autoimmune diseases and fibrosis.
At the end of 2015, the company has a portfolio of five products, including 3 in pre-clinical development phase and 2 in clinical development.